Stimcell Energetics (STME) Interest Coverage Ratio Growth (1y) (2017 - 2024)
Stimcell Energetics (STME) Interest Coverage Ratio Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -71.56% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 68.09% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 28.95% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 34.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 12.01% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -29.36% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 16.91% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -229.93% |
| Feb 29, 2024 | 31.12% |
| Nov 30, 2023 | 80.71% |
| Aug 31, 2023 | 86.84% |
| May 31, 2023 | 75.68% |
| Feb 28, 2023 | 47.81% |
| Nov 30, 2022 | 60.85% |
| Aug 31, 2022 | 68.43% |
| May 31, 2022 | 11.78% |
| Feb 28, 2022 | 12.60% |
| Nov 30, 2021 | -36.07% |
| Aug 31, 2021 | -57.06% |
| May 31, 2021 | 51.64% |
| Feb 28, 2021 | -655.62% |
| Nov 30, 2020 | 70.93% |
| Aug 31, 2020 | 11.87% |
| May 31, 2020 | -134.56% |
| Feb 29, 2020 | -107.37% |
| Nov 30, 2019 | -268.00% |
| Aug 31, 2019 | -130.48% |